Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance. | Cancer Res | 2021 | 34462276 | PubTator, text mining | PubMed |
| Fuzhenghefuzhiyang Formula (FZHFZY) Improves Epidermal Differentiation via Suppression of the Akt/mTORC1/S6K1 Signalling Pathway in Psoriatic Models. | Front Pharmacol | 2021 | 34456715 | PubTator, text mining | PubMed |
| Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention. | Pharmaceutics | 2021 | 34452154 | PubTator, text mining | PubMed |
| Pharmacological Properties of Polyphenols: Bioavailability, Mechanisms of Action, and Biological Effects in In Vitro Studies, Animal Models, and Humans. | Biomedicines | 2021 | 34440278 | PubTator, text mining | PubMed |
| Comparison of Osteosarcoma Aggregated Tumour Models with Human Tissue by Multimodal Mass Spectrometry Imaging. | Metabolites | 2021 | 34436447 | PubTator, text mining | PubMed |
| Necroptosis Underlies Neutrophilic Inflammation Associated with the Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). | J Inflamm Res | 2021 | 34429629 | PubTator, text mining | PubMed |
| mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma. | Cancer Res | 2021 | 34429326 | PubTator, text mining | PubMed |
| Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers. | Nat Commun | 2021 | 34417459 | PubTator, text mining | PubMed |
| Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia. | Front Oncol | 2021 | 34408976 | PubTator, text mining | PubMed |
| Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer. | J Hematol Oncol | 2021 | 34407844 | PubTator, text mining | PubMed |
| Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer. | NPJ Precis Oncol | 2021 | 34404896 | PubTator, text mining | PubMed |
| LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer. | Cell Death Discov | 2021 | 34400617 | PubTator, text mining | PubMed |
| The pathogenesis of mesothelioma is driven by a dysregulated translatome. | Nat Commun | 2021 | 34389715 | PubTator, text mining | PubMed |
| Dietary carbohydrate, particularly glucose, drives B cell lymphopoiesis and function. | iScience | 2021 | 34381967 | PubTator, text mining | PubMed |
| Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway. | Mol Cancer Ther | 2021 | 34376577 | PubTator, text mining | PubMed |
| The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients. | Nat Commun | 2021 | 34373466 | PubTator, text mining | PubMed |
| Ovarian Cancer-Associated Ascites Have High Proportions of Cytokine-Responsive CD56bright NK Cells. | Cells | 2021 | 34359872 | PubTator, text mining | PubMed |
| Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor. | Cancers (Basel) | 2021 | 34359600 | PubTator, text mining | PubMed |
| Parasporin A13-2 of Bacillus thuringiensis Isolates from the Papaloapan Region (Mexico) Induce a Cytotoxic Effect by Late Apoptosis against Breast Cancer Cells. | Toxins (Basel) | 2021 | 34357948 | PubTator, text mining | PubMed |
| Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine. | J Pers Med | 2021 | 34357131 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=31